Synairgen plc (LON:SNG – Get Rating)'s stock price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 22.44 ($0.27) and traded as low as GBX 11 ($0.13). Synairgen shares last traded at GBX 12.50 ($0.15), with a volume of 990,485 shares.

Synairgen Stock Down 13.8 %

The business's fifty day simple moving average is GBX 18.24 and its 200 day simple moving average is GBX 22.44. The stock has a market cap of £25.17 million and a price-to-earnings ratio of -0.51. The company has a current ratio of 6.35, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09.

Synairgen Company Profile

(Get Rating)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.

Read More

• MarketBeat: Week in Review 12/19 – 12/23
• These Steelmakers Deserve A Place On Your 2023 Watch List
• Inflation Cools, Where Does The S&P 500 Go Now
• Cintas Beats Inflation With Operating Leverage
• Your Decision to Buy Palantir May Simply Be a Matter of Time

Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.